Wednesday - October 30, 2024
Ropes & Gray: Ionis Pharmaceuticals Expands Licensing Agreement With Otsuka in Asia-Pacific Region
June 22, 2024
BOSTON, Massachusetts, June 22 -- Ropes and Gray, a law firm, issued the following news:

Ropes & Gray advised Ionis Pharmaceuticals in a license agreement with Otsuka Pharmaceutical Co. Ltd under which Otsuka obtains exclusive rights across the Asia-Pacific region for donidalorsen, an investigational RNA-targeted prophylactic medicine for hereditary angioedema. This license agreement is an extension of the parties existing collaboration for donidalorsen in Europe.

I . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products